Nod Pharmaceuticals Inc - 92121 San Diego, CA

Business Name: Nod Pharmaceuticals Inc
Categorized In: Commercial Biotechnical Research
Address: 9924 Mesa Rim Road, San Diego, CA 92121
Phone Number: (858) 717-0332
Contact Person: William Lee
Website Address: nodpharm.com
NAICS Code: 541711
SIC Code: 8731
Business Type: B2B (Business to Business)
Founding Year: 2005
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $50.000 to $99.999
Share This Business:
Similar Businesses: Genestitute - San Diego, CA 92121
Abide Therapeutics - San Diego, CA 92121
Miltenyi Biotec Inc - San Diego, CA 92121
Ignyta - San Diego, CA 92121
Center For Aquaculture Tech - San Diego, CA 92121
Aires Pharmaceuticals Inc - San Diego, CA 92121
Oranox - San Diego, CA 92121
Rd Biosciences Inc - San Diego, CA 92121
Zenobia Therapeutics - San Diego, CA 92121
Arytha Biosciences LLC - San Diego, CA 92121
Abwiz Bio Inc - San Diego, CA 92121
Advantar Laboratories Inc - San Diego, CA 92121
Proacta Inc - San Diego, CA 92121
Anaptysbio Inc - San Diego, CA 92121
Kinome Scan - San Diego, CA 92121
Dermatrends Inc - San Diego, CA 92121
One World Lab Inc - San Diego, CA 92121
Motivatrx LLC - San Diego, CA 92121
Mapp Biopharmaceutical Inc - San Diego, CA 92121
Fate Therapeutics Inc - San Diego, CA 92121

Nod Pharmaceuticals Inc provides professional Commercial Biotechnical Research from its single location at the coordinates 32.899669,-117.17765.

The company offers B2B variables under the SIC code 8731 and NAICS code 541711, while making an annual revenue of $50.000 to $99.999 and hiring a total of 1 to 4 employees.

Founded in 2005, the company can now be visited at 9924 Mesa Rim Road, San Diego, California 92121 or contacted through representative William Lee at (858) 717-0332.

For frequently asked questions and further inquiries about professional Commercial Biotechnical Research, get to know more about Nod Pharmaceuticals Inc through its company website at nodpharm.com. Engage with this business on its social media platforms through on Twitter and on Facebook.